CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 141 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $77,000 | -55.7% | 386,530 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $174,000 | -10.8% | 386,530 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $195,000 | -78.4% | 386,530 | 0.0% | 0.00% | -77.8% |
| Q1 2018 | $901,000 | -22.7% | 386,530 | -5.9% | 0.01% | -18.2% |
| Q4 2017 | $1,166,000 | -5.0% | 410,676 | -4.4% | 0.01% | +10.0% |
| Q3 2017 | $1,228,000 | +13.3% | 429,374 | -2.1% | 0.01% | +11.1% |
| Q2 2017 | $1,084,000 | -31.8% | 438,739 | -0.4% | 0.01% | -35.7% |
| Q1 2017 | $1,590,000 | +2.0% | 440,305 | 0.0% | 0.01% | +7.7% |
| Q4 2016 | $1,559,000 | +1357.0% | 440,305 | +1564.6% | 0.01% | +1200.0% |
| Q3 2016 | $107,000 | +10600.0% | 26,451 | +146850.0% | 0.00% | – |
| Q4 2015 | $1,000 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,000 | $3,096,000 | 100.00% |
| TSP Capital Management Group, LLC | 698,674 | $1,549,000 | 0.79% |
| Meditor Group Ltd | 6,312,700 | $2,847,000 | 0.61% |
| Telemetry Investments, L.L.C. | 186,200 | $84,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 1,270,500 | $573,000 | 0.03% |
| Benchmark Capital Advisors | 53,400 | $24,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 80,150 | $36,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 80,000 | $36,000 | 0.01% |
| Centiva Capital, LP | 121,720 | $55,000 | 0.01% |
| Overbrook Management Corp | 48,611 | $22,000 | 0.00% |